logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU summary of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (i) New outpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates5.642.130.012.75.32.51.20.621.82321311429
Cocaine6.641.327.012.86.63.21.71.022.2204796157
Stimulants12.358.417.56.12.51.20.31.720.03373519
Hypnotics and sedatives8.622.317.612.312.48.77.410.628.4958313
Hallucinogens17.851.519.84.03.04.00.00.019.410141
Volatile substances51.635.25.52.71.62.70.00.516.918248
Cannabis 34.852.89.02.20.80.30.10.017.0230364901
Other substances 21.043.116.86.45.51.52.23.621.0548227
Total15.845.821.59.04.22.01.00.720.47189023635

Notes:

 : indicates data not available 

 Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LV, HU, MT, NL, AT, RO, SI, SK, FI, SE, HR 

 Last data available from Spain and Malta refer to 2006.Last data available from Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2008 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Tuesday, 30 June 2009